Cancer Therapy: Reimbursement of New Therapeutic Technologies
Williams, Henry M.
Yale Journal of Biology and Medicine. 1992 Mar-Apr; 65(2): 83-97.
Alternatives; Biomedical Technologies; Bone Marrow; Cancer; Drugs; Economics; Federal Government; Food; Government; Government Regulation; Health; Health Care; Health Insurance; Health Insurance Reimbursement; Human Experimentation; Insurance; Investigational Drugs; Legal Aspects; Patient Care; Prognosis; Regulation; Remuneration; Research; Risks and Benefits; Selection for Treatment; Technology; Technology Assessment; Therapeutic Research; Transplantation; Treatment Outcome;
Showing items related by title, author, creator and subject.
Williams, Henry M. (1992-03)
Reproductive and therapeutic cloning, germline therapy, and purchase of gametes and embryos: comments on Canadian legislation governing reproduction technologies Bernier, Louise, 1975-; Gregoire, D. (2004-12)In Canada, the Assisted Human Reproduction Act received royal assent on 29 March 2004. The approach proposed by the federal government responds to Canadians' strong desire for an enforceable legislative framework in the ...
Miller, Henry I. (1990-03)